Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (1031-1040 of 1,212) with videos related to

Pageof 122
Sort By:
Journal of the American College of Cardiology|November 12, 2013
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)Greg Flaker, Renato D Lopes, Sana M Al-Khatib, et al.
Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
Clinical Kidney Journal|September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 24, 2017
Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocolMario Gaudino, John H Alexander, Faisal G Bakaeen, et al.
Colloids and Surfaces. B, Biointerfaces|March 7, 2024
Glycerol- and diglycerol-based polyesters: Evaluation of backbone alterations upon nano-formulation performanceEleni Axioti, Emily G Dixon, Morgan Reynolds-Green, et al.
The Journal of Surgical Research|November 6, 2023
Prospective Study of Risk Factors for Postoperative Atrial Fibrillation After Cardiac SurgeryMichael E Bowdish, Emilia Bagiella, Gennaro Giustino, et al.
Clinical Chemistry|December 3, 2014
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudyZiad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.
International Journal of Cancer|September 4, 2007
Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologistsParveen Bhatti, Jeffery P Struewing, Bruce H Alexander, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2014
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI studyThomas J Povsic, John P Vavalle, John H Alexander, et al.
Pageof 122

Showing results (1031-1040 of 1,212) with videos related to

Sort By:
Pageof 122
Journal of the American College of Cardiology|November 12, 2013
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)Greg Flaker, Renato D Lopes, Sana M Al-Khatib, et al.
Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
Clinical Kidney Journal|September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 24, 2017
Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocolMario Gaudino, John H Alexander, Faisal G Bakaeen, et al.
Colloids and Surfaces. B, Biointerfaces|March 7, 2024
Glycerol- and diglycerol-based polyesters: Evaluation of backbone alterations upon nano-formulation performanceEleni Axioti, Emily G Dixon, Morgan Reynolds-Green, et al.
The Journal of Surgical Research|November 6, 2023
Prospective Study of Risk Factors for Postoperative Atrial Fibrillation After Cardiac SurgeryMichael E Bowdish, Emilia Bagiella, Gennaro Giustino, et al.
Clinical Chemistry|December 3, 2014
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudyZiad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.
International Journal of Cancer|September 4, 2007
Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologistsParveen Bhatti, Jeffery P Struewing, Bruce H Alexander, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2014
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI studyThomas J Povsic, John P Vavalle, John H Alexander, et al.
Pageof 122